South Africa Medtech Regulations Published – Vital Next Steps Still Awaited
Executive Summary
South Africa's new regulatory system has taken another step forward, but, it appears, also one to the side, in a move that observers fear will add extra time to the overall process of getting the country's first medtech-only system fully up and running.
You may also be interested in...
South Africa Reg System Finally Up And Running, But Medtechs Wary Over Costs
South Africa's medical devices and IVDs industry crossed the first major threshold of the new national regulatory system on August 24 – the deadline for South African medtech establishments to register under the new regulations. Momentum is increasing, but so are the costs to industry, and they will ramp up further when product licensing – the next phase – kicks in.
South Africa Medtech Reg: As New System Nears Finish Line, Device-Drug Distinctions Still Need Highlighting
Stakeholders pushing for a dedicated medtech regulatory system in South Africa have been in sight of the finish line on several occasions in recent years, only for obstacles to rise. But a new structure is almost in place with the enactment of key rules this month. The country's device industry group, meanwhile, is still working to ensure the government fully appreciates important distinctions between devices and drugs.
South Africa Finally Gets Medtech Regulations Over The Start Line
After several years of delays, restarts and revisions to plans, South Africa’s medical device regulatory system has taken a big step forward with the setting of a deadline for manufacturers, importers and distributors to license their establishments locally. SAHPRA, the new South African Health Products Regulatory Agency, is also slated to start soon, in spring 2017.